TNXP - tonixpharma.com Company Cash on Hand

Official company branding of Tonix Pharmaceuticals (TNXP)

Dumping to facilitate the sale of speculative products limits growth, as evidenced by the price action of Tonix Pharmaceuticals (TNXP). The cash position demonstrates financial stability, with the value maintained at 0.16. The business relies on a diversified CNS treatment system; however, intense competition for capital and the risk of failed trials create significant challenges for the biopharmaceutical startup.

Company Total Cash Volume: Tonix Pharma (TNXP) for 07/04/2022 - 11/21/2026

Analytical breakdowns for Tonix Pharmaceuticals

Fundamental valuation:TNXP tonixpharma.com
Brand item of Tonix Pharmaceuticals Holding Corp.

Investors assess the financial stability of the issuer by analyzing its liquidity and solvency. The trend in current cash reserves demonstrates the ability of Tonix Pharmaceuticals (TNXP) to cover operating expenses and liabilities without incurring external debt. For Tonix Pharmaceuticals (TNXP), this reserve is critical for funding clinical trials and protecting patents. A stable cash balance confirms the viability of the business model until the commercialization of new drugs.

Competitors of Tonix Pharmaceuticals

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|SXTC: Company Cash Balance|Company Cash Volume EPRX|BHST - Company Cash Reserve|eXoZymes - Company Cash on Hand|Company Cash Volume oramed.com ORMP|ENTX - Company Cash Funds|Company Liquid Assets MindWalk Holdings HYFT|ABVC: Company Cash Volume|Company Cash on Hand Cumberland Pharmaceuticals Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance